OrbiMed Capital GP IV LLC, Director, 10% Owner at Anthera Pharmaceuticals Inc (ANTH), sold 100,000 shares at $8.02 ($810K) on 2011-06-08, disclosed to the SEC on 2011-06-10.
Open-market sale of $810k ANTH by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.02 | 33,000 | $265K | 32.7% |
| 2 | $8.11 | 37,000 | $300K | 37.0% |
| 3 | $8.18 | 30,000 | $245K | 30.3% |
| Total | $8.10 avg | 100,000 | $810K | 100% |
| Filing → |
| BOLD | SELL | 2018-03-12 | $10.2M | — | Filing → |
| BOLD | SELL | 2017-09-11 | $112K | — | Filing → |
| OTIC | SELL | 2015-11-24 | $5.7M | — | Filing → |